{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:47:20Z","timestamp":1791074840552,"version":"4.1.0"},"reference-count":346,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.4065\/74.6.613","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:16:10Z","timestamp":1232759770000},"page":"613-634","source":"Crossref","is-referenced-by-count":225,"title":["The Macrolides: Erythromycin, Clarithromycin, and Azithromycin"],"prefix":"10.4065","volume":"74","author":[{"given":"Salvador","family":"Alvarez-Elcoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Enzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/74.6.613_bib1","series-title":"Biochemistry of Antimicrobial Action","author":"Franklin","year":"1981"},{"key":"10.4065\/74.6.613_bib2","series-title":"Molecular Mechanisms Of Protein Biosynthesis","first-page":"467","article-title":"Inhibitors of protein synthesis","author":"Pestka","year":"1977"},{"key":"10.4065\/74.6.613_bib3","series-title":"Mechanism of Action of Antimicrobial and Antitumor Agents","first-page":"396","article-title":"OleinlckNL The erythromycins","year":"1975"},{"issue":"Suppl C","key":"10.4065\/74.6.613_bib4","first-page":"l","article-title":"Chemistry and mode of action of maerolides","volume":"31","author":"Mazzel","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0079-6468(08)70375-8","article-title":"Semi-synthetic derivatives of erythromycin","volume":"30","author":"Klrst","year":"1993","journal-title":"Prog Med Chem"},{"key":"10.4065\/74.6.613_bib6","first-page":"445","article-title":"Comparative in vitro potencies of nine new maerolides","volume":"14","author":"Fernandas","year":"1988","journal-title":"Drugs fxp Chn Res"},{"key":"10.4065\/74.6.613_bib7","first-page":"137","article-title":"Clarithromycin and azithromycin: new macrolide antibiotics [published erratum appears in ClinPharm 1992.11:308)","volume":"11","author":"Piscitelll","year":"1992","journal-title":"Clin Pharm"},{"key":"10.4065\/74.6.613_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1128\/AAC.32.5.752","article-title":"In vitro activities of azithromycin (CP 62,993). Clarithromycin (A-56268; TE-031), erythromycin roxithromycin. and clindamycin","volume":"32","author":"Barry","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib9","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Fourth Edition-Approved Standard","author":"National Committee for Clinical Laboratory Standards","year":"1997"},{"key":"10.4065\/74.6.613_bib10","doi-asserted-by":"crossref","first-page":"17iai719","DOI":"10.1128\/AAC.32.11.1710","article-title":"Comparative in vitro activities of new 14-. 15-, and 16 rnembered maerolides","volume":"32","author":"Hardy","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jac\/35.4.552","article-title":"Relative potencies of azithromycin, clarithromycin and five other orally administered antibiotics (letterl","volume":"35","author":"Barry","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1099\/00222615-43-5-386","article-title":"Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro","volume":"43","author":"Van Assert","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.4065\/74.6.613_bib13","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/AAC.38.10.2419","article-title":"In vitro activities Of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993","volume":"38","author":"Barry","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1128\/AAC.41.2.478","article-title":"Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae","volume":"41","author":"Thomson","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib15","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1128\/AAC.37.10.2080","article-title":"Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, seattergrams, and regression analyses to compare in vitro activities and describe cross-resistance","volume":"37","author":"Fass","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib16","first-page":"237","article-title":"In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin\/clavuianate, cefaclor, cefuroxime, cefotaxime, etanthromycin, and azithromycin","volume":"51","author":"Oclmcc","year":"1996","journal-title":"ActaClinBelg"},{"key":"10.4065\/74.6.613_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF01962611","article-title":"Comparative in vitro activity of the new oral macrolide azithromycin","volume":"7","author":"Neu","year":"1988","journal-title":"Eur J Clin Microbiol infect D\/s"},{"key":"10.4065\/74.6.613_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/AAC.39.5.1097","article-title":"Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates","volume":"39","author":"Goldstein","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib19","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1128\/AAC.36.6.1241","article-title":"In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans","volume":"36","author":"Pajukanta","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib20","doi-asserted-by":"crossref","first-page":":838","DOI":"10.1007\/BF01967388","article-title":"Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoptasma pneumonias, Mycoplasma hominis and Ureaplasma urealyticum","volume":"9","author":"Renaudln","year":"1990","journal-title":"Eur J Clin Microbiol Infect DiS"},{"key":"10.4065\/74.6.613_bib21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/AAC.38.4.790","article-title":"In vitro and in vivo activities of maerolides against Mycoplasma pneumoniae","volume":"38","author":"IshkJa","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/36.1.219","article-title":"Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents","volume":"36","author":"Nlmmo","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.40.1.212","article-title":"In vitro activities of azithromycin clarithromycin. erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae","volume":"40","author":"Welsh","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/JCM.34.2.479-481.1996","article-title":"Evaluation of in vitro spectra of activity of azithromycin, clanthromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods","volume":"34","author":"Mahattey","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.4065\/74.6.613_bib25","first-page":"313","article-title":"In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis","volume":"41","author":"Lefevre","year":"1993","journal-title":"Pathol Biol (Paris)"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib26","doi-asserted-by":"crossref","first-page":"l","DOI":"10.1093\/jac\/25.suppl_A.1","article-title":"In vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis","volume":"25","author":"Slaney","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib27","first-page":"12","article-title":"In vitro comparison of the activity of doxycycline. tetracycline, erythromycin and a new macrolide, CP 62993. against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum","volume":"53","author":"Rylander","year":"1988","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.4065\/74.6.613_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF01962614","article-title":"In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid","volume":"7","author":"Jones","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib29","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/AAC.31.12.1939","article-title":"Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms","volume":"31","author":"Retsema","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/BF02000410","article-title":"Azithromycin resistance in Campylobacter jejuni and Campylobacter colt","volume":"12","author":"Rautelin","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/AAC.37.5.1203","article-title":"In vitro activity of azithromycin against bacterial enteric pathogens","volume":"37","author":"Gordillo","year":"1993","journal-title":"AnUmicrob Agents Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/25.suppl_A.29","article-title":"In vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella lyphi","volume":"25","author":"Metchock","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib33","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/AAC.33.9.1614","article-title":"In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex","volume":"33","author":"Nalk","year":"1989","journal-title":"Antimicrob Agents Chemotner"},{"key":"10.4065\/74.6.613_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CMR.6.3.266","article-title":"The Mycobacterium avium complex","volume":"6","author":"Inderlied","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"10.4065\/74.6.613_bib35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/106002809402801109","article-title":"New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycodacfertum tuberculosis","volume":"28","author":"Ftapp","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.6.613_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.36.1.180","article-title":"Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. cnefonae-like organisms","volume":"36","author":"Brown","year":"1992","journal-title":"Antimicrob Agents Chemotner"},{"key":"10.4065\/74.6.613_bib37","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/AAC.37.8.1704","article-title":"Comparative in vitro activities of clarithromycin, azithromycin and erythromycin against Borrelia burgdorferi","volume":"37","author":"Dever","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF01968150","article-title":"Comparative antimicrobial activity of the new macrolides against Borrelia burgdorfen","volume":"8","author":"Preac-Murslc","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib39","first-page":"126","article-title":"In vitro and in vivo susceptibility of Borrelia burgdorferi","volume":"6","author":"Murslc","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"10.4065\/74.6.613_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/BF01962617","article-title":"Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents","volume":"7","author":"McNulty","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib41","first-page":"545","article-title":"Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community-acquired pneumococcal disease","volume":"23","author":"Linares","year":"1983","journal-title":"Antimicrrjb 4genfs Cnemoftier"},{"key":"10.4065\/74.6.613_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199201303260503","article-title":"Resistance to erythromycin in group A streptococci","volume":"326","author":"Seppala","year":"1992","journal-title":"NEngl JMed"},{"key":"10.4065\/74.6.613_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/AAC.18.1.118","article-title":"Bacteria static and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp jejuni","volume":"18","author":"Vanhoaf","year":"1980","journal-title":"Antimicrob Agents Chemotner"},{"key":"10.4065\/74.6.613_bib44","first-page":"610","article-title":"Erythromycin esters-comparative in-vivo hydrolysis and bioavail-ability","volume":"20","author":"Eechtol","year":"1976","journal-title":"Curr Ther Res Clin Dip"},{"key":"10.4065\/74.6.613_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000441-196401000-00010","article-title":"Comparison of the blood levels obtained after single and multiple doses of erythromycin estolate and erythromycin stearate","volume":"247","author":"Griffith","year":"1964","journal-title":"Am J Med Sci"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jac\/16.suppl_A.151","article-title":"Pharmacokinetics of macrolides. lincosamides and streptogramins","volume":"16","author":"Osono","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib47","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM197306072882307","article-title":"Transplacental passage of erythromycin and clindamycin","volume":"288","author":"Phlllpson","year":"1973","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(82)90380-4","article-title":"Double blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis","volume":"1","author":"Anders","year":"1982","journal-title":"Lancet"},{"key":"10.4065\/74.6.613_bib49","series-title":"Handbook of Antimicrobial Therapy","author":"Medical Letter","year":"1992"},{"key":"10.4065\/74.6.613_bib50","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/jama.1997.03540460058033","article-title":"Prevention of bacterial endocarditis; recommendations by the American Heart Association","volume":"277","author":"Dajani","year":"1997","journal-title":"JAMA"},{"issue":"RR-1","key":"10.4065\/74.6.613_bib51","first-page":"1","article-title":"1998 guidelines for treatment of sexually transmitted diseases","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal WkfyRep"},{"key":"10.4065\/74.6.613_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/0003-4819-81-1-58","article-title":"Chemical structure of erythro mycin and hepatotoxicity","volume":"81","author":"Tolman","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.6.613_bib53","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/019459988409200615","article-title":"Erythromycin ototoxicity: analysis and conclusions based on 22 case reports","volume":"92","author":"Haydon","year":"1984","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.4065\/74.6.613_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9343(92)90016-5","article-title":"Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia","volume":"92","author":"Swanson","year":"1992","journal-title":"Am J Med"},{"key":"10.4065\/74.6.613_bib55","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.300.6736.1375","article-title":"Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes)","volume":"300","author":"Schoenenberger","year":"1990","journal-title":"BMJ"},{"key":"10.4065\/74.6.613_bib56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/arrd.1983.127.5.581","article-title":"The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis","volume":"127","author":"Relsz","year":"1983","journal-title":"Am fiev Respir Dis"},{"key":"10.4065\/74.6.613_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000137958","article-title":"The effect of erythromycin on the disposition kinetics of warfarin","volume":"28","author":"Bachmann","year":"1984","journal-title":"Pharmacology"},{"key":"10.4065\/74.6.613_bib58","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/clpt.1983.62","article-title":"Effect of erythromycin on carbamazepine kinetics","volume":"33","author":"Wong","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/74.6.613_bib59","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-104-5-660","article-title":"The effects of erythromycin in patients treated with cyclosponne","volume":"104","author":"Martell","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.6.613_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/106002809202600112","article-title":"The new macrolide antibiotics: azithromycin. clarithromycin, dirithromycin, and roxithromycin","volume":"26","author":"Bahal","year":"1992","journal-title":"Ann Pharmacother"},{"issue":"Suppl 3","key":"10.4065\/74.6.613_bib61","first-page":"123","article-title":"Mode of inhibition of protein synthesis by TE031 (A-56268)","volume":"361","author":"Kakegawa","year":"1988","journal-title":"Chemotherapy"},{"key":"10.4065\/74.6.613_bib62","first-page":"317","article-title":"Mode of inhibition of protein synthesis by metabolites of clarithromycin","volume":"38","author":"Kakegawa","year":"1990","journal-title":"Chemotherapy"},{"key":"10.4065\/74.6.613_bib63","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/AAC.34.7.1407","article-title":"Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans","volume":"34","author":"Hardy","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/27.suppl_A.19","article-title":"The activity of clarilhromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactencidal tests","volume":"27","author":"Dabemat","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0732-8893(97)00026-6","article-title":"Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithro-mycin against Haemophilus influenzae using an in vitro pharmaco-dynamic model","volume":"27","author":"Garrison","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib66","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/AAC.41.3.578","article-title":"In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers","volume":"41","author":"Ives","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib67","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/AAC.37.9.1746","article-title":"In vitro activity of azithromycin {CP62.993} against Chlamydia trachomatis and Chlamydia pneumoniae","volume":"37","author":"Agacifldan","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib68","doi-asserted-by":"crossref","first-page":"l","DOI":"10.1093\/jac\/27.suppl_A.1","article-title":"The development of macrolides: clarithromycin in perspective","volume":"27","author":"Neu","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib69","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/AAC.30.6.865","article-title":"In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide","volume":"30","author":"Fernandes","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0732-8893(96)00128-9","article-title":"A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994: the Alexander Project","volume":"25","author":"Washington","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib71","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/22.6.923","article-title":"An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent","volume":"22","author":"Anderson","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib72","first-page":"91","article-title":"The in vitro activity of some 14-, 15- and 16-membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum","volume":"17","author":"Felmingham","year":"1991","journal-title":"Drugs Exp Clin Res"},{"key":"10.4065\/74.6.613_bib73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0732-8893(96)00097-1","article-title":"In vitro activity of macrolides against intracellular Legionella pneumophila","volume":"25","author":"Segretl","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib74","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF01691574","article-title":"Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin. azithromycin and ampicillin","volume":"17","author":"Pontanl","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0732-8893(97)00195-8","article-title":"Surveillance of antimicrobial resistance in Streptococcus pneumoniae. Haemophilus influenzae, and Moraxella catarrhalis in the United States in 19961997 respiratory season","volume":"29","author":"Thomsberry","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib76","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00006454-199704000-00029","article-title":"Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media","volume":"16","author":"Block","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.6.613_bib77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/39.3.411","article-title":"Multicentre in vitro evaluation of the susceptibility of Sfreptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin","volume":"39","author":"Hoogkamp-Korstanje","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib78","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/AAC.40.12.2884","article-title":"Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxe\/la catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib79","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/AAC.40.12.2884","article-title":"Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/38.suppl_A.85","article-title":"Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in western Europe and in the USA","volume":"38","author":"Berk","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib81","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01645362","article-title":"In vitro testing of clarithromycin in combination with ethambutol and rifampicin against Mycobacte-rium avium complex","volume":"19","author":"Stauffer","year":"1991","journal-title":"Infection"},{"key":"10.4065\/74.6.613_bib82","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/AAC.35.3.462","article-title":"Extracellular and intracellular activities of clarithromycin used alone and m association with ethambutol and rifarnpin against fVtycobacienum avium complex","volume":"35","author":"Rastogl","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib83","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jac\/25.4.708","article-title":"Activity in vitro against Toxopfasma gon\u00f3ii of azithromycin and clarithromycin alone and with pyrimethamine [letter]","volume":"25","author":"Derouln","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib84","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1128\/AAC.36.11.2454","article-title":"Activity of clartthromycin alone or in combination with other drugs for treatment of murine toxoplasmosis","volume":"36","author":"Araujo","year":"1992","journal-title":"4nt\/microh Agents Chemother"},{"key":"10.4065\/74.6.613_bib85","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.37.6.1329","article-title":"Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo","volume":"37","author":"Alder","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00003495-199244010-00009","article-title":"Clarithromycin: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential","volume":"44","author":"Peters","year":"1992","journal-title":"Drugs"},{"key":"10.4065\/74.6.613_bib87","first-page":"149","article-title":"Comparative pharmacokinetics of new macrolides","volume":"4","author":"LeBel","year":"1993","journal-title":"Can J Infect Dis"},{"key":"10.4065\/74.6.613_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/j.1552-4604.1992.tb03784.x","article-title":"Drug-food interaction potential of clarithromycin. a new macrolide antimicrobial","volume":"32","author":"Chu","year":"1992","journal-title":"J Clin Pharmacol"},{"key":"10.4065\/74.6.613_bib89","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/AAC.36.5.1147","article-title":"Absolute bioavailability of clarithromycin after oral administration in humans","volume":"36","author":"Chu","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib90","first-page":"52","article-title":"Azithromycin and clarithromycin","volume":"14","author":"Elsenberg","year":"1994","journal-title":"Curr Clin Top infect Dis"},{"key":"10.4065\/74.6.613_bib91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0732-8893(92)90055-X","article-title":"Clarithromycin, a unique macrolide: a pharmacokinetic, microbiological, and clinical overview","volume":"15","author":"Hardy","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib93","first-page":"441","article-title":"Metabolism and disposition of clarithromycin in man","volume":"18","author":"Ferrero","year":"1990","journal-title":"Drug MetabDispos"},{"key":"10.4065\/74.6.613_bib94","first-page":"106","article-title":"Pharmacokinetic drug interactions of macrolides [published erratum appears in Clin Pharmacokinet 1993:24:70]","volume":"23","author":"Perltl","year":"1992","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl C","key":"10.4065\/74.6.613_bib95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/31.suppl_C.77","article-title":"Tissue distribution of dirithromycin: comparison with erythromycin","volume":"31","author":"Bergogne-B\u00e9rezln","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/j.1552-4604.1985.tb02798.x","article-title":"Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses","volume":"25","author":"Yakatan","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"10.4065\/74.6.613_bib97","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2125.1979.tb04716.x","article-title":"The influence of food on the bioavailability of new formulations of erythromycin stearate and base","volume":"8","author":"Rutland","year":"1979","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/31.suppl_E.51","article-title":"Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine","volume":"31","author":"WiWreuer","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib99","first-page":"24","article-title":"Multiple dose pharmacokinetics of azithromycin following 1 hour intravenous infusions in hospitalized patients with community acquired pneumonia [abstract]","volume":"37","author":"Thakker","year":"1997","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0195-6701(91)90215-T","article-title":"The pharmacokinetics of clarithromycin and its 14-OH metabolite","volume":"19","author":"Davey","year":"1991","journal-title":"J Hosp Infect"},{"key":"10.4065\/74.6.613_bib101","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/j.1552-4604.1993.tb04692.x","article-title":"Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics","volume":"33","author":"Chu","year":"1993","journal-title":"J Clin Pharmacol"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/27.suppl_A.117","article-title":"A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia","volume":"27","author":"Anderson","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib103","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.100.6.1503","article-title":"The safety and efficacy of clarithromycin in patients with Legionella pneumonia","volume":"100","author":"Hamedani","year":"1991","journal-title":"Chesi"},{"key":"10.4065\/74.6.613_bib104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1185\/03007999009111488","article-title":"Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis","volume":"12","author":"Scagllone","year":"1990","journal-title":"Curr Med Res Opm"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/27.suppl_A.67","article-title":"Clarithromycin versus penicillin in the treatment of streptococcal pharyngitis","volume":"27","author":"Levenstein","year":"1991","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib106","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/27.suppl_A.75","article-title":"A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis","volume":"27","author":"Bachand","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1185\/03007999009111487","article-title":"Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis","volume":"12","author":"Marchi","year":"1990","journal-title":"Curr Med Res Opin"},{"key":"10.4065\/74.6.613_bib108","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2165\/00003495-199753060-00006","article-title":"Clarithromycin: a review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients","volume":"53","author":"Langtry","year":"1997","journal-title":"Drugs"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/27.suppl_A.91","article-title":"Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis","volume":"27","author":"Bachand","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib110","first-page":"33","article-title":"Safety and efficacy of clarithromycin in the treatment of acute mild to moderate respiratory tract infections","volume":"84","author":"O'Neill","year":"1991","journal-title":"Ir Med J"},{"key":"10.4065\/74.6.613_bib111","first-page":"244","article-title":"Treatment of commu nily acquired pneumonia: a randomized controlled trial comparing Clarithromycin (CM) and erythromycin (EM) [abstract]","volume":"31","author":"Chlen","year":"1991","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib112","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.103.3.697","article-title":"Treatment of community acquired pneumonia: a multicenter, double-blind, randomized study Comparing clarithromycin with erythromycin","volume":"103","author":"Chlen","year":"1993","journal-title":"Chest"},{"key":"10.4065\/74.6.613_bib113","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1378\/chest.104.5.1393","article-title":"Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections","volume":"104","author":"Neu","year":"1993","journal-title":"Chest"},{"key":"10.4065\/74.6.613_bib114","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01728910","article-title":"Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis","volume":"21","author":"Adam","year":"1993","journal-title":"Infection"},{"key":"10.4065\/74.6.613_bib115","first-page":"309","article-title":"Safety and efficacy of clarithromycin (C) compared to erythromycin (E) in the treatment (Tx) of bacterial skin or skin structure infections (SSSIs) [abstract]","volume":"30","author":"Northcutt","year":"1990","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib116","first-page":"309","article-title":"Safety and efficacy of clarithromycin (C) compared to cefadroxil (CEF) in the treatment of mild to moderate bacterial skin or skin structure infections (SSSIs) [abstract]","volume":"30","author":"Millikan","year":"1990","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib117","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-4362.1993.tb02843.x","article-title":"Clarithromycin in the treatment of skin and skin structure infections: two multicenter Clinical studies","volume":"32","author":"Parish","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.4065\/74.6.613_bib118","unstructured":"Gupta 5, Siepman H. Comparative safety and efficacy of clarithromycin vs standard agents in the treatment of mild to moderate bacterial skin or skin structure infections [abstract). In: Proceedings and Abstracts of the First International Conference on the Macrolides, Azalides, and Streptogramins; 1992; Santa Fe (NM)"},{"issue":"Suppl 3","key":"10.4065\/74.6.613_bib119","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1097\/00006454-199312003-00004","article-title":"Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children","volume":"12","author":"Hebert","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.6.613_bib120","doi-asserted-by":"crossref","first-page":"14891493","DOI":"10.1097\/00002030-199410000-00018","article-title":"Ward JW (Adult\/Adolescent Spectrum of HIV Disease Project Group). Surveillance of AIDS-defining conditions in the United States","volume":"8","author":"Jones","year":"1994","journal-title":"AIDS"},{"key":"10.4065\/74.6.613_bib121","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1164\/ajrccm\/144.3_Pt_1.564","article-title":"Activity of clarithromycin against rVtycooacfeWum avium infection in patients with the acquired immune deficiency syndrome: a controlled clinical trial","volume":"144","author":"Dautzenberg","year":"1991","journal-title":"Am Rev Resptr Dis"},{"key":"10.4065\/74.6.613_bib122","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archinte.1993.00410030074010","article-title":"Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobactenum avium infections in patients with acquired immunodeficiency syndrome","volume":"153","author":"Dautzenberg","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.6.613_bib123","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7326\/0003-4819-121-12-199412150-00001","article-title":"Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: a randomized, double blind, dose ranging study in patients with AIDS","volume":"121","author":"Chaisson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.6.613_bib124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/clinids\/17.1.7","article-title":"Mycobacterium avium complex infection and AIDS: advances in theory and practice","volume":"17","author":"Benson","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199608083350602","article-title":"A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, elhambutol, and clarithromycin versus rifampin. ethambutol, clofazimine, and ciprofloxacin","volume":"335","author":"Shafran","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00002030-199703110-00008","article-title":"Clarithromycin and elhambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection","volume":"11","author":"Chaisson","year":"1997","journal-title":"AIDS"},{"issue":"Pro-gram Suppl","key":"10.4065\/74.6.613_bib127","first-page":"27","article-title":"Comparison of two doses of clarithromycin in a randomized trial of four 3-drug regimens for treatment of disseminated Mycobacterium avium complex disease in AIDS: excess mortality associated with high-dose clarithromycin [abstract)","volume":"ll","author":"Conn","year":"1996","journal-title":"Int Conf AIDS"},{"key":"10.4065\/74.6.613_bib128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF02113501","article-title":"A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections","volume":"25","author":"Dautzenberg","year":"1997","journal-title":"Infection"},{"issue":"RR-9","key":"10.4065\/74.6.613_bib129","first-page":"14","article-title":"Recommendations on prophylaxis and therapy for disseminated Mycobacferium avium complex for adults and adolescents infected with human immunodeficiency virus: U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex","volume":"42","author":"Canters for Disease Control and Prevention","year":"1993","journal-title":"MMWR Morb Mortal WKIyRep"},{"issue":"Suppl 1","key":"10.4065\/74.6.613_bib130","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/clinids\/21.Supplement_1.S12","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview","volume":"21","author":"Kaplan","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.4065\/74.6.613_bib131","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1093\/clinids\/21.Supplement_1.S72","article-title":"Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus","volume":"21","author":"Ostroff","year":"1995","journal-title":"Clin infect Dis"},{"key":"10.4065\/74.6.613_bib132","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1086\/514999","article-title":"Randomized, open-label trial of azittvomycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection","volume":"27","author":"Ward","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib133","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Resp\/r Crit Care Med"},{"key":"10.4065\/74.6.613_bib134","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.4065\/74.6.613_bib135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199608083350603","article-title":"A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome","volume":"335","author":"Pierce","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib136","first-page":"106","article-title":"Clarithromycin (CL) plus rifabutin (RFB) for MAC prophylaxis: evidence for a drug interaction [abstract]","volume":"1","author":"Datrl 001 Study Group","year":"1993","journal-title":"Natl Conf Hum Retroviruses Relat Infect"},{"key":"10.4065\/74.6.613_bib137","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00042560-199708010-00005","article-title":"Prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS; a cost-effectiveness analysis","volume":"15","author":"Freedberg","year":"1997","journal-title":"J Acqulr Immune Defic Syndr Hum Retrovirol"},{"key":"10.4065\/74.6.613_bib138","first-page":"91","volume":"3","author":"Benson","year":"1996","journal-title":"Conf Retro Opportun Infect"},{"key":"10.4065\/74.6.613_bib139","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0962-8479(96)90070-2","article-title":"Clarithromycin against Mycobacterium avium complex infections","volume":"77","author":"Heifets","year":"1996","journal-title":"Tuber Lung Dis"},{"key":"10.4065\/74.6.613_bib140","first-page":"251253","article-title":"Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin","volume":"124","author":"Bordet","year":"1997","journal-title":"Ann Dermatol Venereot"},{"key":"10.4065\/74.6.613_bib141","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-5876(97)00146-8","article-title":"Recurrent therapy resistant mastoiditis by Mycobacterium chelonae abscessus, a nontuberculous Mycobacterium","volume":"43","author":"van Aarem","year":"1998","journal-title":"int J Pediatr Otorhinolaryngol"},{"key":"10.4065\/74.6.613_bib142","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0149-2918(97)80088-4","article-title":"Treatment of nontuberculous mycobacterial infections: role of cfarithromycin and azithromycin","volume":"19","author":"Tartaglkuie","year":"1997","journal-title":"Clin Ther"},{"key":"10.4065\/74.6.613_bib143","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1076-0512(97)00130-1","article-title":"A surgical wound infection due to iWycobacferium chelonae successfully treated with clarithromycin","volume":"23","author":"Saluja","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.4065\/74.6.613_bib144","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(95)30834-2","article-title":"Atypical mycobacte-rial infection of the orbit","volume":"102","author":"Klapper","year":"1995","journal-title":"Ophthalmology"},{"key":"10.4065\/74.6.613_bib145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s001050050523","article-title":"Postoperative infection with Mycobacterium chelonae","volume":"47","author":"Engelhardt","year":"1996","journal-title":"Hautarzt"},{"key":"10.4065\/74.6.613_bib146","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/ndt\/10.7.1234","article-title":"Disseminated cutaneous infection due to Mycobacterium chelonae in a patient with rheumatoid arthritis, amyloidosis, and renal failure","volume":"10","author":"Foislund","year":"1995","journal-title":"Nephrot Dial Transplant"},{"key":"10.4065\/74.6.613_bib147","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/clinids\/20.5.1441","article-title":"Successful treatment of Mycobacterium abscessus infections with multidrug regimens containing clarithromycin [letter]","volume":"20","author":"Mushatt","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib148","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00000441-199801000-00009","article-title":"Ceivical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome","volume":"315","author":"Butt","year":"1998","journal-title":"Am J Med Sci"},{"key":"10.4065\/74.6.613_bib149","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1128\/AAC.32.12.1758","article-title":"In vitro and in vivo activities of macrolides against Mycobacterium leprae","volume":"32","author":"Franzblau","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/168.1.188","article-title":"Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy","volume":"168","author":"Jl","year":"1993","journal-title":"J Infect Dis"},{"key":"10.4065\/74.6.613_bib151","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/AAC.38.3.515","article-title":"Clinical trial of clarithromycin for lepromatous leprosy","volume":"38","author":"Chan","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib152","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.41.2.326","article-title":"Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy","volume":"41","author":"Banerjee","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib153","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.40.9.2137","article-title":"Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacm, against Mycobacterium leprae in patients","volume":"40","author":"Jl","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib154","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-199306000-00004","article-title":"Clarithromycin for the eradication of Helicobacter pylori","volume":"16","author":"Graham","year":"1993","journal-title":"J Clin Gastroenterol"},{"key":"10.4065\/74.6.613_bib155","first-page":"8","article-title":"Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report","volume":"41","author":"European Helicobacter pylori Study Group","year":"1997","journal-title":"Guf"},{"key":"10.4065\/74.6.613_bib156","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00019048-199706010-00005","article-title":"Helicobacter pylori: pathogenic factor in the etiology of gastric diseases","volume":"6","author":"Syngal","year":"1997","journal-title":"Infect Dis Clin Pratt"},{"key":"10.4065\/74.6.613_bib157","first-page":"1860","article-title":"Clarithromycin as monotherapy for eradication of Heiicobacte\/- pylori: a randomized, double-blind trial","volume":"88","author":"Peterson","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/74.6.613_bib158","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2036.1994.tb00170.x","article-title":"Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection","volume":"8","author":"Thijs","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.4065\/74.6.613_bib159","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003495-199651010-00010","article-title":"Clarithromycin and omeprazole as Helicobacter pylori eradication therapy in patients with H. pyiori associated gastric disorders","volume":"51","author":"Markham","year":"1996","journal-title":"Drugs"},{"key":"10.4065\/74.6.613_bib160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gut.35.3.323","article-title":"Eradication of Helicobacter pyiori with clarithromycin and omeprazole","volume":"35","author":"Logan","year":"1994","journal-title":"Gut"},{"key":"10.4065\/74.6.613_bib161","first-page":"649652","article-title":"Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter py\/ori-associated duodenal ulcer","volume":"92","author":"Lazzaroni","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/74.6.613_bib162","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00019048-199606000-00003","article-title":"Clarithromycin and azithromycin","volume":"5","author":"Barza","year":"1996","journal-title":"Infect Dis ClinPraci"},{"key":"10.4065\/74.6.613_bib163","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1128\/AAC.39.1.276","article-title":"Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus [letter]","volume":"39","author":"Lacassin","year":"1995","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.4065\/74.6.613_bib164","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1128\/AAC.35.10.2049","article-title":"Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS","volume":"35","author":"Fernandez-Martin","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib165","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/clinids\/20.4.1076","article-title":"Breakthrough cerebral toxoplasmosis in patients with AIDS who are being treated with clarithromycin (letter]","volume":"20","author":"Raffl","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib166","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/106002809703100314","article-title":"Drug interactions of macrolides: emphasis on dirithromycin","volume":"31","author":"Watkins","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.6.613_bib167","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/106002809703100314","article-title":"Drug interactions of macrolides: emphasis on dirithromycin","volume":"31","author":"Watklns","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.6.613_bib168","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00006454-199702000-00002","article-title":"The expanding spectrum of Bartonella infections. II. Cat-scratch disease","volume":"16","author":"Bass","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.6.613_bib169","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/AAC.40.2.468","article-title":"Clarithromycin in treatment of early Lyme disease: a pilot study","volume":"40","author":"Dattwyler","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib170","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2165\/00002018-199308050-00003","article-title":"Overview of the tolerability profile of clarithromycin in preclinical and clinical trials","volume":"8","author":"Guay","year":"1993","journal-title":"Drug Saf"},{"key":"10.4065\/74.6.613_bib171","first-page":"10251026","article-title":"Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection [letter]","volume":"18","author":"Yew","year":"1994","journal-title":"din Infect Dis"},{"key":"10.4065\/74.6.613_bib172","first-page":"394","article-title":"Fulminant hepatic failure associated with clarithromycin","volume":"91","author":"Shalwen","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/74.6.613_bib173","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/0003-4819-125-8-199610150-00031","article-title":"Pancreatitis induced by clarithromycin [letter}","volume":"125","author":"Liviu","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.6.613_bib174","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/clinids\/22.1.175","article-title":"A clarithromycin-induced myasthenic syndrome","volume":"22","author":"Pljpers","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0732-8893(93)90112-K","article-title":"Drug intolerance to high-dose clarithromycin among elderly patients","volume":"16","author":"Wallace","year":"1993","journal-title":"Diagn MicroOiol Infect Dis"},{"key":"10.4065\/74.6.613_bib176","first-page":"138","article-title":"Dose escalation study to determine the safety, maximally tolerated dose (MTD), and pharmacokinetics of clarithromycin (ciari) with zidovudine (zdv) in HIV-infected persons [abstract]","volume":"31","author":"Polls","year":"1991","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib177","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0025-7125(16)30040-2","article-title":"Azithromycin and clarithromycin","volume":"79","author":"Sehlossberg","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.4065\/74.6.613_bib178","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003088-198510010-00003","article-title":"Pharmacokinetic interactions of the macrolide antibiotics","volume":"10","author":"Ludden","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"10.4065\/74.6.613_bib179","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/106002809703100711","article-title":"Digoxin toxicity secondary to clarithromycin therapy","volume":"31","author":"Nawarskas","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.6.613_bib180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1365-2125.1997.54310.x","article-title":"The mechanism of cyclosporine toxicity induced by clarithromycin","volume":"43","author":"Splcer","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.4065\/74.6.613_bib181","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/clinids\/24.1.92","article-title":"Clarithromycin associated digoxin toxicity in the elderly","volume":"24","author":"Brown","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib182","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(05)62825-5","article-title":"Life-threatening interaction between clarithromycin and disopyramide [letter]","volume":"349","author":"Paar","year":"1997","journal-title":"Lancet"},{"key":"10.4065\/74.6.613_bib183","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1177\/106002809603001221","article-title":"Interaction between clarithromycin and oral anticoagulants [letter]","volume":"30","author":"Grau","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.6.613_bib184","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.40.7.1715","article-title":"Effect of combination therapy with ciprofloxacin and clarithromycin on the-ophylline pharmacokinetics in healthy volunteers","volume":"40","author":"Glllum","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00002018-199615030-00002","article-title":"Cisapride: drug interactions of clinical significance [published erratum appears in Drug Saf 1997;17:196]","volume":"15","author":"Bedford","year":"1996","journal-title":"Drug Saf"},{"key":"10.4065\/74.6.613_bib186","first-page":"400","article-title":"Interaction between midazolam and clarithromycin: comparison with azithromycin","volume":"34","author":"Yeates","year":"1996","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.4065\/74.6.613_bib187","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/j.1875-9114.1996.tb02949.x","article-title":"Possible role of the intestinal P-450 enzyme system in a cyclosporine-darithromycin interaction","volume":"16","author":"Sketrls","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.4065\/74.6.613_bib188","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/AAC.39.6.1355","article-title":"Pharmacokinetics of clarithromycin and zidovudine in patients with AIDS","volume":"39","author":"Vance","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib189","first-page":"163","article-title":"Drug interaction between clarithromycin and oral zidovudine in HIV-1 infected patients [abstract]","volume":"53","author":"Gustavson","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/74.6.613_bib190","first-page":"201","article-title":"Clarithromycin and zidovudine pharmacokinetic study |abstract]","volume":"10","author":"Vance","year":"1994","journal-title":"Int Conf AIDS"},{"key":"10.4065\/74.6.613_bib191","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/AAC.41.8.1709","article-title":"Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection","volume":"41","author":"Polls","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib192","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/clinids\/22.4.716","article-title":"Effect of clarithromycin on the pharmacokinetics of 2',3'-dideoxyinosine in patients who are seropositive for human immunodeficiency virus","volume":"22","author":"Glllum","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib193","doi-asserted-by":"crossref","first-page":"111114","DOI":"10.1128\/AAC.37.1.111","article-title":"MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages","volume":"37","author":"Mor","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib194","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/ajrccm\/145.4_Pt_1.856","article-title":"Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium","volume":"145","author":"Heifets","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.4065\/74.6.613_bib195","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.35.4.760","article-title":"Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice","volume":"35","author":"Gelber","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib196","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.35.3.579","article-title":"Effectiveness of clarithromycin and minocyciine alone and in combination against experimental Mycobacterium leprae infection in mice","volume":"35","author":"Jl","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib197","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/25.suppl_A.39","article-title":"Comparison of the acid stability of azithromycin and erythromycin A","volume":"25","author":"Fiese","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib198","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jac\/26.4.533","article-title":"The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin","volume":"26","author":"Cooper","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib199","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/AAC.33.3.277","article-title":"In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection","volume":"33","author":"Gladue","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib200","doi-asserted-by":"crossref","first-page":"850552","DOI":"10.1007\/BF01975839","article-title":"An open study to compare the pharmacokinetics. safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers","volume":"10","author":"Coates","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib201","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.37.2.314","article-title":"Pharmacokinetics or azithromycin in pediatric patients after oral administration of multiple doses of suspension","volume":"37","author":"Nahata","year":"1993","journal-title":"Arrtimicrob Agents Chemother"},{"issue":"Suppl C","key":"10.4065\/74.6.613_bib202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jac\/37.suppl_C.37","article-title":"The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension","volume":"37","author":"Foulds","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib203","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AAC.40.3.825","article-title":"Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye","volume":"40","author":"Jaruratanaslrlkul","year":"1996","journal-title":"Aflflmfcro Agents Chemother"},{"issue":"Suppl C","key":"10.4065\/74.6.613_bib204","doi-asserted-by":"crossref","first-page":"l","DOI":"10.1093\/jac\/37.suppl_C.1","article-title":"Azithromycin-review of key chemical, pharmacokinetic and microbiological features","volume":"37","author":"Lode","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/31.suppl_E.57","article-title":"Pharmacokinetics of azithromycin in patients with impaired hepatic function","volume":"31","author":"Mazzel","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib206","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/106002809502900913","article-title":"Macrolides versus azalides: a drug interaction update","volume":"29","author":"Amsdsn","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.6.613_bib207","first-page":"512","article-title":"Azithromycin drug interactions","volume":"43","author":"Felstead","year":"1995","journal-title":"Patfiol Biol (Paris)"},{"key":"10.4065\/74.6.613_bib208","unstructured":"Amsden GW. Review of the drug interaction profile of azithromycin [abstractl. in: Proceedings and Abstracts of the Second International Conference on the Macrolides, Azalides, and Streptogramins: 1994 Jan 19-22; Venice (Italy)"},{"key":"10.4065\/74.6.613_bib209","unstructured":"Gardner MJ, Coates PE, HllligosB DM, et al. Lack of effect of azithromycin on pharmacokinetics of iheophylline in man [abstract]. In: Proceedings of the VIII Mediterranean Congress of Chemotherapy, 1992 May 24 29; Athens (Greece)"},{"key":"10.4065\/74.6.613_bib210","first-page":"213","article-title":"Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam","volume":"46","author":"Zlmmermann","year":"1996","journal-title":"Arzneimittetforschung"},{"key":"10.4065\/74.6.613_bib211","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF03258467","article-title":"Comparison of the effect of the macrolide antibiotics erythromycin, clarithromycin and azithromycin on terfenadine steady state pharmacokinetics and electrocardiographs parameters","volume":"7","author":"Honlg","year":"1994","journal-title":"Drug Invest"},{"key":"10.4065\/74.6.613_bib212","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0009-9236(95)90247-3","article-title":"Azithromycin and terfenadine: lack of drug interaction","volume":"58","author":"Harris","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/74.6.613_bib213","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/AAC.36.5.1013","article-title":"Once-a-week azithromycin in AIDS patients: tolerability. kinetics, and effects on zidovudine disposition","volume":"36","author":"Chave","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib214","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/j.1552-4604.1991.tb03701.x","article-title":"The effects of an antacid or cimetidineonthe serum concentrations of azithromycin","volume":"31","author":"Foulds","year":"1991","journal-title":"J Clin Pharmacol"},{"issue":"Suppl C","key":"10.4065\/74.6.613_bib215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jac\/37.suppl_C.143","article-title":"Paediatric safety of azithromycin: world wide experience","volume":"37","author":"Treadway","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib216","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/AAC.40.4.1005","article-title":"Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children","volume":"40","author":"Paclfico","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib217","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF01691958","article-title":"Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis\/tonsillitis","volume":"15","author":"O'Doherty","year":"1996","journal-title":"Eur J Ciin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib218","first-page":"195","article-title":"Azithromycin suspension vs penicillin suspension in treatment of children with streptococcal pharyngitis [abstract]","volume":"53","author":"Still","year":"1993","journal-title":"C\/r'n Pharmacol Ther"},{"issue":"Suppl","key":"10.4065\/74.6.613_bib219","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00006454-199504002-00007","article-title":"Management of pediatric patients with group A beta-hemolytic Streptococcus pharyngitis: treatment options","volume":"14","author":"Still","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.6.613_bib220","first-page":"120","article-title":"Treatment of streptococcal pharyngitis m children with five days of azithromycin suspension [abstract]","volume":"34","author":"Still","year":"1994","journal-title":"Program Abstr Intersci Conl Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib221","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/pai.1992.6.167","article-title":"Therapeutic considerations for management of olitis media, sinusitis, and tonsillopharyngitis","volume":"6","author":"Pichichero","year":"1992","journal-title":"Pediatr Asthma Allergy Immunol"},{"issue":"Suppl","key":"10.4065\/74.6.613_bib222","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/00006454-199504002-00005","article-title":"Bacterial susceptibility and tympanocentesis in acute otrtis media","volume":"14","author":"McCarty","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl","key":"10.4065\/74.6.613_bib223","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00006454-199609009-00001","article-title":"Incidence of antibiotic-resistant Streptococcus pneumonias and bela-lactamase-positive Haemophilus influenzae'm clinical isolates from patients with olitis media","volume":"15","author":"MeLInn","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib224","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/31.suppl_E.73","article-title":"A comparative study of azithromycin and amoxycillin in paediatric patients with acute otrtis media","volume":"31","author":"Moris","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl","key":"10.4065\/74.6.613_bib225","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00006454-199609009-00003","article-title":"A multicenter, open label trial of azithromycin vs. amoxieillin\/clavulanate for the management of acute otitis media in children","volume":"15","author":"AronovKz","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/31.suppl_E.65","article-title":"Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children","volume":"31","author":"Daniel","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl","key":"10.4065\/74.6.613_bib227","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00006454-199504002-00003","article-title":"Issues concerning antibiotic use in child care settings","volume":"14","author":"Khurana","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl","key":"10.4065\/74.6.613_bib228","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/00006454-199609009-00005","article-title":"A multicenter, randomized, open label comparison of azithromycin and amoxicillin\/clavulanate in acute otitis media among children attending day care or school","volume":"15","author":"Khurana","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl","key":"10.4065\/74.6.613_bib229","first-page":"S20S23","article-title":"A multicenter, double blind comparison of azithromycin and amoxicillin\/clavulanate for the treatment of acute otitis media in children","volume":"15","author":"McLinn","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.6.613_bib230","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF01690872","article-title":"Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin\/clavuianic acid in the treatment of paediatric patients with otitis media","volume":"14","author":"Prlncipl","year":"1995","journal-title":"Eurj Clln Microbiol Infect Dis"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib231","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1093\/jac\/31.suppl_E.81","article-title":"Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children","volume":"31","author":"Schaad","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl C","key":"10.4065\/74.6.613_bib232","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/37.suppl_C.63","article-title":"An open study to compare azithromycin with cef aclor in the treatment of children with acute otitis media","volume":"37","author":"Rodriguez","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib233","first-page":"345","article-title":"Bacteriologic response to acute otitis media caused by Haemophilus intluenzae treated with azithromycin [abstract]","volume":"37","author":"Dagan","year":"1997","journal-title":"Program Abstr Inter sci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib234","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.40.12.2765","article-title":"Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections","volume":"40","author":"Roord","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib235","first-page":"807","article-title":"Azithromycin vs amox\/clav in pediatric community-acquired LRTIs","volume":"14","author":"Arguedas","year":"1997","journal-title":"Infect Med"},{"key":"10.4065\/74.6.613_bib236","first-page":"286","article-title":"Safety and efficacy of azithromycin in the treatment of community acquired pneumonia in children [abstract]","volume":"36","author":"Harris","year":"1996","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"issue":"Suppl C","key":"10.4065\/74.6.613_bib237","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/37.suppl_C.125","article-title":"A comparative study of the efficacy, safety and tolerabil ity of azithromycin and cefaclor in the treatment of children with acute skin and\/or soft tissue infections","volume":"37","author":"Montero","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib238","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/31.suppl_E.103","article-title":"A comparative study of the efficacy, safely and tolerance of azithromycin, rjicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections","volume":"31","author":"Rodrlguez-Solares","year":"1993","journal-title":"J Antimicrob Chemotner"},{"key":"10.4065\/74.6.613_bib239","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/0002-9378(91)90562-6","article-title":"The role of azalide antibiotics in the treatment of Chlamydia","volume":"164","author":"Johnson","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jac\/25.suppl_A.109","article-title":"Azithromycin in the treatment of sexually transmitted disease","volume":"25","author":"Stelngrimsson","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib241","doi-asserted-by":"crossref","first-page":"115121","DOI":"10.1093\/jac\/25.suppl_A.115","article-title":"Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by IVeissena and Chlamydia species","volume":"25","author":"Lassus","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib242","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM199209243271304","article-title":"{Azithromycin for Chlamydlal Infections Study Group). A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis","volume":"327","author":"Martin","year":"1992","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib243","first-page":"961965","article-title":"Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents","volume":"122","author":"Hammerserilag","year":"1993","journal-title":"J Pediatr"},{"key":"10.4065\/74.6.613_bib244","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/095646249100200404","article-title":"Azithromycin vs doxycycline in the treatment of non gonococcal urethritis","volume":"2","author":"Whatley","year":"1991","journal-title":"Int J STO AIDS"},{"key":"10.4065\/74.6.613_bib245","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF01989972","article-title":"Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by","volume":"11","author":"Ossewaarde","year":"1992","journal-title":"Chlamydia trachomatis, Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib246","first-page":"325","article-title":"A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males","volume":"68","author":"Nllsen","year":"1992","journal-title":"Genitouhn Med"},{"issue":"Suppl 3A","key":"10.4065\/74.6.613_bib247","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/0002-9343(91)90401-I","article-title":"Clinical toleration and safety of azithromycin","volume":"91","author":"Hopkins","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/74.6.613_bib248","first-page":"7","article-title":"Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis","volume":"8","author":"Nuovo","year":"1995","journal-title":"J Am Board Earn Pract"},{"key":"10.4065\/74.6.613_bib249","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-124-4-199602150-00002","article-title":"Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis","volume":"124","author":"Magld","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.6.613_bib250","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007435-199509000-00002","article-title":"The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women","volume":"22","author":"Haddix","year":"1995","journal-title":"Sex Transm Dis"},{"key":"10.4065\/74.6.613_bib251","first-page":"419","article-title":"Comparison of azithromycin and erythromycin for Chlamydia cervicitis in pregnancy [abstract]","volume":"170","author":"Edwards","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.4065\/74.6.613_bib252","first-page":"61","article-title":"Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy","volume":"84","author":"Bush","year":"1994","journal-title":"Obsfef Gynecol"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib253","doi-asserted-by":"crossref","first-page":"177183","DOI":"10.1093\/jac\/31.suppl_E.177","article-title":"Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males","volume":"31","author":"Lauharanta","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib254","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/31.suppl_E.185","article-title":"Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men","volume":"31","author":"Lister","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib255","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jama.1995.03530070043027","article-title":"Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men: a randomized double-blind study","volume":"274","author":"Stamm","year":"1995","journal-title":"JAMA"},{"key":"10.4065\/74.6.613_bib256","series-title":"Intravenous azithromycin [product monograph]","year":"1997"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib257","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/31.suppl_E.193","article-title":"Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women","volume":"31","author":"Waugh","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib258","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007435-199401000-00009","article-title":"Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men","volume":"21","author":"Stelngrimsson","year":"1994","journal-title":"Sex Transm DiS"},{"key":"10.4065\/74.6.613_bib259","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007435-199403000-00010","article-title":"Multicenter trial of single-dose azithromycin vs. ceftriaxane in the treatment of uncomplicated gonorrhea","volume":"21","author":"Handsfleld","year":"1994","journal-title":"Sex Transm Dis"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/25.suppl_A.91","article-title":"Efficacy of azithromycin for therapy of active syphilis in the rabbit model","volume":"25","author":"Lukehart","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib261","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinids\/19.3.486","article-title":"Pilot study of azithromycin for treatment of primary and secondary syphilis","volume":"19","author":"Verdon","year":"1994","journal-title":"Clm Infect Dis"},{"key":"10.4065\/74.6.613_bib262","unstructured":"Mashkilleyson AL, Gomberg MA, Kutln SA, et al. Azithromycin in early syphilis [abstract]. In: Proceedings and Abstracts of the Second International Conference on the Macrolides, Azalides, and Streptogramins; 1994 Jan 19-22; Venice [Italy), p 73"},{"key":"10.4065\/74.6.613_bib263","unstructured":"Issoire C, Casln I, Perenet F, et al. Pilot study of azithromycin in the treatment of chancroid caused by Haemophilus ducreyi [abstract]. In: Program and Abstracts of the First Conference on Infectious Diseases; 1990; Montreal (Canada"},{"key":"10.4065\/74.6.613_bib264","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00007435-199407000-00010","article-title":"Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin","volume":"21","author":"Tyndall","year":"1994","journal-title":"Sex Transm Dis"},{"key":"10.4065\/74.6.613_bib265","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/clinids\/21.2.409","article-title":"Comparison of azithromycin and ceftriaxone for the treatment of chancroid","volume":"21","author":"Martin","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.4065\/74.6.613_bib266","first-page":"9","article-title":"Treatment of chancroid with azithromycin","volume":"7","author":"Ballard","year":"1996","journal-title":"IntJSTDAIDS"},{"key":"10.4065\/74.6.613_bib267","first-page":"17","article-title":"Pilot study of azithromycin in the treatment of genital donovanosis","volume":"72","author":"Bowden","year":"1996","journal-title":"Gerwfourin Med"},{"key":"10.4065\/74.6.613_bib268","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0149-2918(95)80046-8","article-title":"An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis","volume":"17","author":"Amin","year":"1995","journal-title":"Clin Ther"},{"key":"10.4065\/74.6.613_bib269","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/BF01691214","article-title":"Efficacy and safety of azithromycin versus phenoxymethylpeniciilin in the treatment of acute maxillary sinusitis","volume":"15","author":"Hayle","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib270","first-page":"363","article-title":"Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and arnoxyciUin","volume":"19","author":"Felstead","year":"1991","journal-title":"JlntMedRes"},{"issue":"Suppl 3A","key":"10.4065\/74.6.613_bib271","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(91)90397-G","article-title":"A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis","volume":"91","author":"Hooton","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/74.6.613_bib272","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/030006059101900503","article-title":"Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin","volume":"19","author":"Daniel","year":"1991","journal-title":"J Int Med Res"},{"issue":"Suppl 3A","key":"10.4065\/74.6.613_bib273","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/0002-9343(91)90399-I","article-title":"Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections","volume":"91","author":"Dark","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/74.6.613_bib274","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/BF01975846","article-title":"Azithromycin versus cefaclor in the treat ment of acute bacterial pneumonia","volume":"10","author":"Klnasewitz","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib275","doi-asserted-by":"crossref","first-page":"437439","DOI":"10.1007\/BF01968024","article-title":"Comparative study of azithromycin and amoxicillin\/clavulanic acid in the treatment of lower respiratory tract infections","volume":"10","author":"Balmes","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib276","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jac\/31.suppl_E.147","article-title":"A single blind comparison of threeday azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections","volume":"31","author":"Hoepelman","year":"1993","journal-title":"J Antimicmb Chemother"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib277","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/31.suppl_E.153","article-title":"Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection","volume":"31","author":"Bradbury","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"Suppf C","key":"10.4065\/74.6.613_bib278","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/37.suppl_C.115","article-title":"Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections","volume":"37","author":"Laurent","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib279","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/516275","article-title":"Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease","volume":"26","author":"Gray","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib280","first-page":"352","article-title":"Azithromycin in the treatment of community-acquired pneumonia due to Chlamydia pneumoniae [abstract]","volume":"37","author":"Hammerschlag","year":"1997","journal-title":"Program Abstr tntersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib281","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/030006059101900602","article-title":"Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues","volume":"19","author":"Daniel","year":"1991","journal-title":"J Int Med Res"},{"key":"10.4065\/74.6.613_bib282","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF01975848","article-title":"Double blind, double dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections","volume":"10","author":"Klani","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 3A","key":"10.4065\/74.6.613_bib283","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1016\/0002-9343(91)90400-R","article-title":"Azithromycin compared with cephalexin in the treatment of skin and skin structure infections","volume":"91","author":"Mallory","year":"1991","journal-title":"Am J Med"},{"issue":"Suppl E","key":"10.4065\/74.6.613_bib284","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/31.suppl_E.129","article-title":"Once daily azithromycin in the treatment of adult skin and skin-structure infections","volume":"31","author":"Amaya-Tapla","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib285","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM198909283211310","article-title":"Mycobacterium avium complex and the normal host: the other side of the coin [editorial]","volume":"321","author":"Iseman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib286","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0140-6736(91)91965-W","article-title":"Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS","volume":"338","author":"Young","year":"1991","journal-title":"Lancet"},{"key":"10.4065\/74.6.613_bib287","first-page":"106","article-title":"Azithromycin therapy for disseminated Mycobacterium avium-intracellulare in AIDS patients [abstract]","volume":"1","author":"Berry","year":"1993","journal-title":"Natl Conf Hum Retroviruses Relat Infect"},{"key":"10.4065\/74.6.613_bib288","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-3476(05)81380-0","article-title":"Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome","volume":"124","author":"Huston","year":"1994","journal-title":"J Pediatr"},{"key":"10.4065\/74.6.613_bib289","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJM199608083350610","article-title":"Advances in the prevention and treatment of Mycobacterium avium disease [editorial]","volume":"335","author":"Horsburgh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib290","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199309163291228","article-title":"Recommendations on prophylaxis and therapy far disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus","volume":"329","author":"Masur","year":"1993","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib291","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM199309163291202","article-title":"Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS","volume":"329","author":"Nightingale","year":"1993","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib292","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJM199608083350604","article-title":"Prophylaxis against disseminated Mycobacierium avium complex with weekly azithromycin, daily rifabutin, or both","volume":"335","author":"Havlir","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/74.6.613_bib293","first-page":"210","article-title":"Clarithromycin prophylaxis against MAC in AIDS [abstract]","volume":"34","author":"Baker","year":"1994","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib294","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinids\/23.5.983","article-title":"Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/clinids\/24.5.958","article-title":"Relationship of adverse events to serum drug levels in patients receiving high lose azithromycin for mycobacterial lung disease","volume":"24","author":"Brown","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib296","unstructured":"Wallace RJ, Griffith DE, Brown BA, Murphy D, Glrard W, Cegiersky JP. Initial results of three times weekly azithromycin in treatment regimens of Mycobacterium avium-jntracei\/uiare (MAI) lung disease in non-AIDS [abstract]. In Proceedings and Abstracts of the Third International Conference on Macrotides, Azalides, and Strepto-gramins; 1996 Jan 24-26; Lisbon (Portugal)"},{"key":"10.4065\/74.6.613_bib297","first-page":"367","article-title":"Treatment of typhoid fever with azithromycin vs chloramphenicol in a randomized multicenter trial in India labstractj","volume":"37","author":"Butler","year":"1997","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib298","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/clinids\/21.3.536","article-title":"Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent","volume":"21","author":"Kmchner","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib299","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/clinids\/22.5.868","article-title":"Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994","volume":"22","author":"Murphy","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-126-9-199705010-00004","article-title":"Treatment of shigellosis. V. Comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial","volume":"126","author":"Khan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.6.613_bib301","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0035-9203(96)90269-2","article-title":"Azithromycin prophylaxis prevents epidemic dysentery","volume":"90","author":"Shanks","year":"1996","journal-title":"Trans R Soc TropMedHyg"},{"key":"10.4065\/74.6.613_bib302","doi-asserted-by":"crossref","first-page":"453456","DOI":"10.1016\/0140-6736(93)91591-9","article-title":"Randomised controlled trial of single-dose azithromycin in treatment of trachoma","volume":"342","author":"Bailey","year":"1993","journal-title":"Lancet"},{"key":"10.4065\/74.6.613_bib303","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/clinids\/24.3.363","article-title":"A comparison of oral azithromycin with topical oxytetracycline\/polymyxin for the treatment of trachoma in children","volume":"24","author":"Dawson","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib304","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/37.3.483","article-title":"In-vitro activity of azithromycin against intracellular Helicobacter pylori","volume":"37","author":"Hulten","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib305","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/BF01975843","article-title":"Azithromycin levels in plasma and gastric tissue, juice and mucus","volume":"10","author":"Harrison","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib306","first-page":"258","article-title":"Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin","volume":"91","author":"Bertonl","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/74.6.613_bib307","first-page":"403","article-title":"Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth","volume":"90","author":"al-Assi","year":"1995","journal-title":"Am J Gastraenterol"},{"key":"10.4065\/74.6.613_bib308","first-page":"817","article-title":"The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection [letter]","volume":"91","author":"Tursi","year":"1996","journal-title":"Am J Gastroenteral"},{"key":"10.4065\/74.6.613_bib309","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1365-2036.1996.88260000.x","article-title":"Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers","volume":"10","author":"Pilotto","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.4065\/74.6.613_bib310","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/37.4.849","article-title":"A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication [letter]","volume":"37","author":"Caselli","year":"1996","journal-title":"J Antimicrab Chemother"},{"key":"10.4065\/74.6.613_bib311","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00042737-199701000-00012","article-title":"Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly' effective for the eradication of Helicobacter pylori","volume":"9","author":"Caselli","year":"1997","journal-title":"Eur J Gastroenteral Hepatol"},{"issue":"Suppl A","key":"10.4065\/74.6.613_bib312","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/25.suppl_A.33","article-title":"In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin","volume":"25","author":"Johnson","year":"1990","journal-title":"J Antimicrab Chemother"},{"key":"10.4065\/74.6.613_bib313","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90270-L","article-title":"Treatment of early Lyme disease","volume":"92","author":"Massarotti","year":"1992","journal-title":"Am J Med"},{"key":"10.4065\/74.6.613_bib314","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/30.4.543","article-title":"Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethyl-penicillin","volume":"30","author":"Strle","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib315","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01728915","article-title":"Azithromycin versus penicillin V for the treatment of early Lyme borreliosis","volume":"21","author":"Weber","year":"1993","journal-title":"Infection"},{"key":"10.4065\/74.6.613_bib316","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","article-title":"Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial","volume":"124","author":"Luft","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.6.613_bib317","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01780661","article-title":"Azlthrornycin and doxycycline for treatment of Borrelia culture-positive erythema migrans","volume":"24","author":"Strle","year":"1996","journal-title":"Infection"},{"key":"10.4065\/74.6.613_bib318","first-page":"364","article-title":"Single dose azithromycin compared to a four dose rifampin regimen for the eradication of meningococcal nasopharyngeal carriage [abstract]","volume":"37","author":"Girgis","year":"1997","journal-title":"Progrem Abstr Intersci Conf Antimicrab Agents Chemother"},{"key":"10.4065\/74.6.613_bib319","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.1992.47.378","article-title":"Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro","volume":"47","author":"Gingras","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.4065\/74.6.613_bib320","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(94)92526-7","article-title":"Azithromycin prophylaxis against a chloroquineresistant strain of Plasmodium falciparum [published erratum appears in Lancet 1994;344:69]","volume":"343","author":"Kuschner","year":"1994","journal-title":"Lancet"},{"key":"10.4065\/74.6.613_bib321","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1995.52.159","article-title":"Activity of azithromycln as a blood schizonticide against rodent and human plasmodia in vivo","volume":"52","author":"Andersen","year":"1995","journal-title":"Am J Trap Med Hyg"},{"key":"10.4065\/74.6.613_bib322","first-page":"379","article-title":"The tolerance to daily azithromycin malaria prophylaxis by adults in Irian Jaya, Indonesia [abstract]","volume":"37","author":"Taylor","year":"1997","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib323","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(95)92712-3","article-title":"Effects of azithromycin on malariometric indices in The Gambia","volume":"346","author":"Sadiq","year":"1995","journal-title":"Lancet"},{"key":"10.4065\/74.6.613_bib324","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1086\/515071","article-title":"Malaria prophylaxis using azithromycin: a double-blind, placebocontrolled trial in Irian Jaya, Indonesia","volume":"28","author":"Taylor","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib325","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/infdis\/168.5.1289","article-title":"Efficacy of azithromycin for treating Babesia microti infection in the hamster model","volume":"168","author":"Weiss","year":"1993","journal-title":"J Infect Dis"},{"key":"10.4065\/74.6.613_bib326","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4269\/ajtmh.1996.55.219","article-title":"Atovaquone in the treatment of Babesia microti infections in hamsters","volume":"55","author":"Wittner","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.4065\/74.6.613_bib327","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1128\/AAC.37.9.1993","article-title":"In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gonoii","volume":"37","author":"Cantin","year":"1993","journal-title":"Amimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib328","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/AAC.32.5.755","article-title":"Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gond","volume":"32","author":"Araujo","year":"1988","journal-title":"Antimicroo Agents Chemother"},{"key":"10.4065\/74.6.613_bib329","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/34.1.111","article-title":"Evaluation ofthe efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis","volume":"34","author":"Dumas","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.6.613_bib330","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1128\/AAC.36.5.997","article-title":"Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis","volume":"36","author":"Derouin","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib331","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF02000407","article-title":"Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS","volume":"12","author":"Saba","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/74.6.613_bib332","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0140-6736(92)90132-M","article-title":"Azithromycin for cerebral toxoplasmosis [letter] [published erratum appears in Lancet 1992; 339:1124","volume":"339","author":"Farthing","year":"1992","journal-title":"J Lancet"},{"key":"10.4065\/74.6.613_bib333","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0163-4453(96)92393-2","article-title":"Response to oral and intravenous azithromycin in a patient with Toxoplasma encephalitis and AIDS","volume":"33","author":"Wlselka","year":"1996","journal-title":"J Infect"},{"key":"10.4065\/74.6.613_bib334","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00002030-199411004-00059","article-title":"Results from recent therapeutic trials for opportunistic infections from the United States","volume":"8","author":"Hardy","year":"1994","journal-title":"AIDS"},{"key":"10.4065\/74.6.613_bib335","first-page":"366","article-title":"Mycobacterium abscessus infections treated with azithromycin [abstract]","volume":"37","author":"Garcla-Diaz","year":"1997","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib336","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/JCM.34.1.227-229.1996","article-title":"Microbiological findings about pulmonary cryptosporidiosis in two AIDS patients","volume":"34","author":"Dupont","year":"1996","journal-title":"J Ctin Microbiol"},{"key":"10.4065\/74.6.613_bib337","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-3476(96)70258-5","article-title":"Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus","volume":"129","author":"Hicks","year":"1996","journal-title":"J Pediatr"},{"key":"10.4065\/74.6.613_bib338","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1258\/0956462971919543","article-title":"Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis","volume":"8","author":"Blanshard","year":"1997","journal-title":"Int J STD AIDS"},{"key":"10.4065\/74.6.613_bib339","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/clinids\/17.2.264","article-title":"Rapid response of AIDS-related bacillary angiomatosis to azithromycin","volume":"17","author":"Guerra","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib340","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/517061","article-title":"Azithromycin for the treatment of cat-scratch disease","volume":"26","author":"Chia","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.6.613_bib341","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/oxfordjournals.ndt.a027166","article-title":"Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin","volume":"11","author":"Hoque","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.4065\/74.6.613_bib342","first-page":"157","article-title":"Infections due to Rhodococcus eaui in three HIV-infected patients: microbiological findings and antibiotic susceptibility","volume":"14","author":"Mascelllno","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.4065\/74.6.613_bib343","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1128\/AAC.41.8.1673","article-title":"Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis","volume":"41","author":"Rouse","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.6.613_bib344","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0025-7125(16)30054-2","article-title":"The growing threat of antibiotic-resistant Streptococcus pneumoniae","volume":"79","author":"Lonks","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.4065\/74.6.613_bib345","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.1994.03510470035031","article-title":"Emergence of drug-resistant pneumococcal infections in the United States","volume":"271","author":"Brelman","year":"1994","journal-title":"JAMA"},{"key":"10.4065\/74.6.613_bib346","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.1997.03550110039033","article-title":"Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians","volume":"278","author":"Gonzales","year":"1997","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611641402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611641402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:57:22Z","timestamp":1738907842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611641402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":346,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S0025619611641402"],"URL":"https:\/\/doi.org\/10.4065\/74.6.613","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}